Founded in October of 2000, the ImpactRx® Network is the source of an unprecedented intelligence database that tracks the real-time promotional initiatives of the pharmaceutical industry and links this activity to the physician prescribing.

Based in Mount Laurel, New Jersey, ImpactRx® is the nation's first Promotion Research Organization (PRO) for the pharmaceutical industry. It is a private company with investment financing provided by Mediphase Venture Partners (http://www.mediphaseventure.com), Oxford Bioscience Partners (http://www.oxbio.com), Merck Capital Ventures (http://www.merckcapitalventures.com) and 3i (http://www.3i.com). With a proprietary network comprised of the nation's highest-prescribing physicians, ImpactRx® is the sole source of physician-level data that directly links the impact of physician promotion to prescribing decisions.

ImpactRx® technology enables the company to collect daily and process the most timely, accurate, and sensitive information on the perceptions and activities of high-volume prescribing physicians, and in turn provide pharmaceutical companies with the ability to diagnose and predict the efficiency and effectiveness of their sales and marketing initiatives.

Physicians in the ImpactRx® Network upload daily to the ImpactRx® database in which the details of all promotional activity are managed longitudinally. In addition to sales representative visits, information is also collected on all meetings and events attended. For two days each week, physicians capture information on all patient visits (patient identity is non-identifiable), capturing the diagnosis, drug treatment, and samples distributed.